The HASTINGS CENTER REPORT, published by WILEY, is a leading journal in the fields of bioethics, health policy, and the philosophical underpinnings of healthcare. Established in 1971, this influential publication provides a critical platform for the discussion of ethical issues in health, medicine, and biotechnology, highlighting the intersection between ethical theory and practical health challenges. The journal achieves remarkable academic stature, achieving Q1 rankings in both Issues, Ethics and Legal Aspects and Philosophy, alongside Q2 standings in Health Policy and Health (social science) categories, reflecting its broad interdisciplinary impact. With its wide readership and rigorous peer-review process, the HASTINGS CENTER REPORT serves as an essential resource for researchers, practitioners, and students dedicated to advancing ethical perspectives in health-related discourse. While the journal operates under traditional access options, its contributions resonate deeply within the academic community, fostering informed dialogue on pressing ethical dilemmas and policy considerations in a rapidly evolving healthcare landscape.

Drugs Habits and Social Policy is an esteemed academic journal published by Emerald Group Publishing Ltd that focuses on the intersection of drug habits and the evolving landscape of social policy. With an ISSN of 2752-6739 and E-ISSN of 2752-6747, this journal contributes significantly to the fields of Clinical Psychology, Health Policy, and Public Health, and is ranked in the Q3 category across multiple disciplines in the 2023 categorizations. Featuring research that spans from 2022 to 2024, the journal provides a platform for critical insights and evidence-based discussions that are essential for understanding the social implications of drug use. Despite its current quartile ranking, the journal aims to elevate discourse among researchers, professionals, and students alike, reinforcing its commitment to impactful scholarship that can inform policy and practice. The journal is based in the United Kingdom, with its operations housed at Floor 5, Northspring 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND. As a pivotal resource in its field, Drugs Habits and Social Policy invites contributions that can shape the future of health policy and improve societal outcomes.

PUBLIC HEALTH REPORTS is a premier journal in the field of public health, published by SAGE PUBLICATIONS INC in the United States. With its ISSN 0033-3549 and E-ISSN 1468-2877, this esteemed publication has been an influential voice in the discipline since its inception in 1945. Recognized for its rigorous scholarship, it currently holds a distinguished Q1 ranking in the 2023 category of Public Health, Environmental and Occupational Health, emphasizing its significance with a Scopus rank of #186 out of 665, placing it in the 72nd percentile. The journal aims to disseminate high-quality research that addresses pressing health issues and promotes evidence-based practices, making it a vital resource for researchers, professionals, and students alike. Although it is not an open-access journal, PUBLIC HEALTH REPORTS continues to offer extensive insights and advancements pertinent to the global public health landscape, thereby fostering a deeper understanding and engagement with critical health determinants. Researchers and health practitioners are encouraged to contribute to this dynamic forum where knowledge and innovation converge.

MEDICINE SCIENCE AND THE LAW is a prestigious journal published by SAGE PUBLICATIONS INC, focused on the intersection of law, health policy, and ethical issues as they pertain to medicine. With a long-standing history dating back to 1960, this journal has become a crucial platform for scholars and professionals alike to share and disseminate research that shapes the evolving legal landscape surrounding health care practices. It holds notable positions in the academic community, ranking in the Q3 category for Health Policy and Issues, Ethics and Legal Aspects, and achieving a distinguished Q1 ranking in Law as of 2023. With rigorous peer-review standards and a commitment to publishing high-quality research, MEDICINE SCIENCE AND THE LAW is invaluable for those exploring the critical legal challenges and ethical dilemmas faced within the healthcare sector. Research contributions are vital for informing policy and practice, ensuring that the journal remains a relevant and essential resource for researchers, practitioners, and students dedicated to the intersection of law and medicine.

Medecine & Droit, an esteemed journal published by ELSEVIER MASSON, CORP OFF, serves as a vital resource for the intersection of law and medicine. Since its inception in 1995, this journal has facilitated scholarly discourse by publishing innovative research, case studies, and reviews that explore the complexities of legal frameworks impacting medical practice and public health. Although currently classified in the fourth quartile within both the Law and Medicine (miscellaneous) categories for 2023, its contributions are important for legal professionals and healthcare providers seeking to navigate the evolving landscape of medical laws. With an ISSN of 1246-7391 and E-ISSN 1873-6475, it provides essential insights and stimulates interdisciplinary collaboration within academia. Authors and researchers are encouraged to contribute and engage with critical topics shaping the future of medicine and law through this essential publication.

Monash Bioethics Review, published by SPRINGER HEIDELBERG, is a leading journal in the interdisciplinary realm of bioethics, dedicated to exploring critical issues at the intersection of health policy, philosophy, and the social sciences. With an impressive impact factor placing it in Q1 in Philosophy and notable rankings across disciplines, including Q3 in Health Policy and Medicine, it serves as an essential platform for researchers, professionals, and students alike. This journal not only aims to foster robust discourse on ethical dilemmas but also seeks to contribute to policymaking through rigorous analysis and research. Covering articles from its inception in 1994 to the present, Monash Bioethics Review remains committed to addressing contemporary ethical challenges in medicine and society, making it a vital resource for those keen on navigating the complexities of bioethical thought.

BMJ Global Health is a premier open-access journal published by the BMJ Publishing Group, dedicated to advancing the field of global health through the dissemination of high-quality research, innovative ideas, and impactful policy analysis. Established in 2016 and based in the United Kingdom, this journal has rapidly ascended to prominence, evidenced by its solid impact factor and ranking in the Q1 category for both Health Policy and Public Health, Environmental and Occupational Health. With its commitment to open access, BMJ Global Health ensures that vital research is freely available to enhance public discourse and inform decision-making processes around the world. The journal welcomes contributions that address pressing global health challenges and offers researchers an influential platform to shape health practices and policies. With Scopus rankings placing it in the top percentile of its categories, BMJ Global Health is indispensable for anyone seeking to stay at the forefront of health discourse and practice.

South African Journal of Bioethics and Law, published by HEALTH & MEDICAL PUBLISHING GROUP, stands as a vital academic platform for discussions at the intersection of bioethics and legal studies. With an ISSN of 1999-7639, this journal has embraced an Open Access model since 2008, ensuring global accessibility for researchers, practitioners, and students alike. Based in South Africa, the journal operates from PRIVATE BAG X1, PINELANDS, CAPE TOWN 7430, and features diverse articles that span a multitude of pertinent topics across health professions, law, and public health. It proudly holds a Q3 ranking in Health Professions and Law sectors, affirming its status within the scholarly community. Notably, for the year 2023, it has achieved impressive placements in Scopus ranks, reinforcing its commitment to disseminating high-quality research and fostering dialogues that influence policy and practice in these critical domains. Researchers exploring the intricate ethical and legal dimensions of healthcare will find this journal an indispensable resource.

HEALTH CARE ANALYSIS, published by SPRINGER, is a distinguished journal that has been contributing to the field of Health Policy and related disciplines since its inception in 1993. With a significant focus on the intricate issues, ethics, and legal aspects surrounding healthcare, this journal holds a prominent status reflected in its Q2 rankings across various categories, including Health Policy, Health (social science), and Issues, Ethics and Legal Aspects. As of 2023, it ranks in the top quartiles of its respective fields, indicating robust scholarly engagement and impact within the academic community. Although the journal is not open access, it remains accessible to a wide audience through institutional subscriptions, making it an essential resource for researchers, healthcare professionals, and policy-makers seeking to advance their understanding of complex healthcare systems and ethical considerations. Positioned in the Netherlands, HEALTH CARE ANALYSIS continues to drive critical dialogue and research, ensuring its relevance in shaping future healthcare policies and practices.

The Journal of Community Genetics, published by SPRINGER HEIDELBERG, is an influential Open Access journal dedicated to advancing the field of genetics in community settings. Since its inception in 2000, this journal has provided a platform for comprehensive interdisciplinary research that encompasses the critical intersections of genetics, public health, and epidemiology. Situated in Germany, the journal has positioned itself prominently within the academic community, evidenced by its 2023 impact rankings, which place it in the Q3 category for both Epidemiology and Genetics (clinical) and Q2 for Public Health, Environmental and Occupational Health. With an expanding scope that includes innovative research from 2010 to 2024, the journal aims to foster dialogue among researchers, healthcare professionals, and policymakers, ultimately driving advancements in community health genetics. The open access model ensures that this vital information is readily available to a global audience, reinforcing its commitment to public health improvement and genetic literacy.